217 related articles for article (PubMed ID: 19591824)
1. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
Lerner M; Harada M; Lovén J; Castro J; Davis Z; Oscier D; Henriksson M; Sangfelt O; Grandér D; Corcoran MM
Exp Cell Res; 2009 Oct; 315(17):2941-52. PubMed ID: 19591824
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM
Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991
[TBL] [Abstract][Full Text] [Related]
4. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
[TBL] [Abstract][Full Text] [Related]
5. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
[TBL] [Abstract][Full Text] [Related]
8. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
9. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
[TBL] [Abstract][Full Text] [Related]
10. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
11. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.
Chung EY; Dews M; Cozma D; Yu D; Wentzel EA; Chang TC; Schelter JM; Cleary MA; Mendell JT; Thomas-Tikhonenko A
Cancer Biol Ther; 2008 Nov; 7(11):1758-64. PubMed ID: 18708755
[TBL] [Abstract][Full Text] [Related]
12. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
[TBL] [Abstract][Full Text] [Related]
13. Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia.
Wu DM; Wen X; Han XR; Wang S; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Chen GQ; Lu J; Zheng YL
Mol Cell Biol; 2018 Oct; 38(20):. PubMed ID: 30037980
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
[TBL] [Abstract][Full Text] [Related]
15. Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455.
Xu B; Gong X; Zi L; Li G; Dong S; Chen X; Li Y
Cancer Sci; 2019 May; 110(5):1676-1685. PubMed ID: 30838724
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma.
Ma W; Zhang CQ; Dang CX; Cai HY; Li HL; Miao GY; Wang JK; Zhang LJ
Biomed Pharmacother; 2019 May; 113():108655. PubMed ID: 30849637
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA Dleu2 affects proliferation, migration and invasion ability of laryngeal carcinoma cells through triggering miR-16-1 pathway.
Xie ZZ; Xiao ZC; Song YX; Li W; Tan GL
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1963-1970. PubMed ID: 29687850
[TBL] [Abstract][Full Text] [Related]
18. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
19. Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication.
Quan R; Wei L; Zhu S; Wang J; Cao Y; Xue C; Yan X; Liu J
Sci Rep; 2016 Jun; 6():27917. PubMed ID: 27302568
[TBL] [Abstract][Full Text] [Related]
20. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
